Secondary Metabolites from Marine-Derived Bacteria with Antibiotic and Antibiofilm Activities against Drug-Resistant Pathogens †

Keyphrases

• Actinobacteria 25%
• Amino Acid Derivatives 25%
• Amphotericin B 25%
• Antibiofilm 100%
• Antibiotic Activity 100%
• Bacterial Secondary Metabolites 25%
• Bioactive Compounds 50%
• Biofilm Formation 25%
• Biosynthetic Origin 25%
• Candida Albicans (C. albicans) 25%
• Drug Candidates 25%
• Drug-resistant Microbes 25%
• Group-based 25%
• Marine Bacteria 75%
• Marine-derived Bacteria 100%
• Methicillin-resistant Staphylococcus Aureus 25%
• Mixed Origin 25%
• Multidrug-resistant Mycobacterium Tuberculosis 25%
• Multidrug-resistant Pathogens 100%
• New Antibiotics 25%
• Pathogenic Microorganisms 25%
• Polyketide Derivatives 25%
• Potential Biological Activity 25%
• Secondary Metabolites 100%
• Staphylococcus Epidermidis (S. epidermidis) 25%
• Streptomyces 25%
• Terpenoids 25%
• Test Bacteria 25%
• Vancomycin-resistant Enterococci 25%

Immunology and Microbiology

• Actinobacteria 33%
• Amino Acid 33%
• Biofilm 33%
• Biological Activity 33%
• Candida Albicans 33%
• Infectious Agent 100%
• Marine Bacterium 100%
• Methicillin-Resistant Staphylococcus Aureus 66%
• Methicillin-Resistant Staphylococcus Epidermidis 33%
• Microorganism 33%
• Multidrug-Resistant Pathogen 33%
• Mycobacterium Tuberculosis 33%
• Pathogenic Microbes 33%
• Secondary Metabolite 100%
• Streptomyces 33%
• Vancomycin-Resistant Enterococcus 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Actinobacteria 25%
• Amino Acid Derivative 25%
• Amphotericin B 25%
• Antibiotics 25%
• Biological Activity 25%
• Candida Albicans 25%
• Infectious Agent 100%
• Lead Compound 25%
• Marine Bacterium 75%
• Methicillin-Resistant Staphylococcus Aureus 50%
• Methicillin-Resistant Staphylococcus Epidermidis 25%
• Microorganism 50%
• Mycobacterium Tuberculosis 25%
• Polyketide 25%
• Streptomyces 25%
• Terpenoid 25%
• Vancomycin-Resistant Enterococcus 25%